Altered leukocyte protein kinase activity in atopic dermatitis

David M. Trask, Sai C. Chan, Scott E. Sherman, Jon Hanifin

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Previous studies have demonstrated elevated cyclic-AMP-specific phosphodiesterase (PDE) activity in mononuclear leukocytes (MNL) from patients with atopic dermatitis (AD). We questioned whether increased kinase activation could account for this observation. In these studies, we measured abnormally lower basal calcium/phospholipid-dependent protein kinase (PK-C) phosphorylation in MNL from patients with AD. Basal cAMP-dependent protein kinase (PK-A) phosphorylation was concomitantly higher in MNL from patients with AD. These results are in agreement with earlier reports that PK-A activity may have a negative influence on PK-C activity in certain cell systems. Stimulation with the H1-histamine agonist, thiazolylethylamine (TEA), of MNL from normal donors but not patients with AD, resulted in statistically significant increases in PK-C phosphorylation. This implies receptor down regulation or functional desensitization in AD cells. Altered basal protein kinase phosphorylation and abnormal response to selective histamine agonists seen in MNL from patients with AD could explain elevated PDE activity.

Original languageEnglish (US)
Pages (from-to)526-531
Number of pages6
JournalJournal of Investigative Dermatology
Volume90
Issue number4
StatePublished - Apr 1988

Fingerprint

Mononuclear Leukocytes
Atopic Dermatitis
Protein Kinases
Phosphorylation
Leukocytes
Histamine Agonists
Phosphoric Diester Hydrolases
Protein Kinase C
Cyclic AMP-Dependent Protein Kinases
Cyclic AMP
Phosphotransferases
Down-Regulation
Chemical activation
Tissue Donors

ASJC Scopus subject areas

  • Dermatology

Cite this

Altered leukocyte protein kinase activity in atopic dermatitis. / Trask, David M.; Chan, Sai C.; Sherman, Scott E.; Hanifin, Jon.

In: Journal of Investigative Dermatology, Vol. 90, No. 4, 04.1988, p. 526-531.

Research output: Contribution to journalArticle

Trask, David M. ; Chan, Sai C. ; Sherman, Scott E. ; Hanifin, Jon. / Altered leukocyte protein kinase activity in atopic dermatitis. In: Journal of Investigative Dermatology. 1988 ; Vol. 90, No. 4. pp. 526-531.
@article{1c4547cda27e4da0ad150a9d470f9065,
title = "Altered leukocyte protein kinase activity in atopic dermatitis",
abstract = "Previous studies have demonstrated elevated cyclic-AMP-specific phosphodiesterase (PDE) activity in mononuclear leukocytes (MNL) from patients with atopic dermatitis (AD). We questioned whether increased kinase activation could account for this observation. In these studies, we measured abnormally lower basal calcium/phospholipid-dependent protein kinase (PK-C) phosphorylation in MNL from patients with AD. Basal cAMP-dependent protein kinase (PK-A) phosphorylation was concomitantly higher in MNL from patients with AD. These results are in agreement with earlier reports that PK-A activity may have a negative influence on PK-C activity in certain cell systems. Stimulation with the H1-histamine agonist, thiazolylethylamine (TEA), of MNL from normal donors but not patients with AD, resulted in statistically significant increases in PK-C phosphorylation. This implies receptor down regulation or functional desensitization in AD cells. Altered basal protein kinase phosphorylation and abnormal response to selective histamine agonists seen in MNL from patients with AD could explain elevated PDE activity.",
author = "Trask, {David M.} and Chan, {Sai C.} and Sherman, {Scott E.} and Jon Hanifin",
year = "1988",
month = "4",
language = "English (US)",
volume = "90",
pages = "526--531",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Altered leukocyte protein kinase activity in atopic dermatitis

AU - Trask, David M.

AU - Chan, Sai C.

AU - Sherman, Scott E.

AU - Hanifin, Jon

PY - 1988/4

Y1 - 1988/4

N2 - Previous studies have demonstrated elevated cyclic-AMP-specific phosphodiesterase (PDE) activity in mononuclear leukocytes (MNL) from patients with atopic dermatitis (AD). We questioned whether increased kinase activation could account for this observation. In these studies, we measured abnormally lower basal calcium/phospholipid-dependent protein kinase (PK-C) phosphorylation in MNL from patients with AD. Basal cAMP-dependent protein kinase (PK-A) phosphorylation was concomitantly higher in MNL from patients with AD. These results are in agreement with earlier reports that PK-A activity may have a negative influence on PK-C activity in certain cell systems. Stimulation with the H1-histamine agonist, thiazolylethylamine (TEA), of MNL from normal donors but not patients with AD, resulted in statistically significant increases in PK-C phosphorylation. This implies receptor down regulation or functional desensitization in AD cells. Altered basal protein kinase phosphorylation and abnormal response to selective histamine agonists seen in MNL from patients with AD could explain elevated PDE activity.

AB - Previous studies have demonstrated elevated cyclic-AMP-specific phosphodiesterase (PDE) activity in mononuclear leukocytes (MNL) from patients with atopic dermatitis (AD). We questioned whether increased kinase activation could account for this observation. In these studies, we measured abnormally lower basal calcium/phospholipid-dependent protein kinase (PK-C) phosphorylation in MNL from patients with AD. Basal cAMP-dependent protein kinase (PK-A) phosphorylation was concomitantly higher in MNL from patients with AD. These results are in agreement with earlier reports that PK-A activity may have a negative influence on PK-C activity in certain cell systems. Stimulation with the H1-histamine agonist, thiazolylethylamine (TEA), of MNL from normal donors but not patients with AD, resulted in statistically significant increases in PK-C phosphorylation. This implies receptor down regulation or functional desensitization in AD cells. Altered basal protein kinase phosphorylation and abnormal response to selective histamine agonists seen in MNL from patients with AD could explain elevated PDE activity.

UR - http://www.scopus.com/inward/record.url?scp=0023880065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023880065&partnerID=8YFLogxK

M3 - Article

C2 - 3351335

AN - SCOPUS:0023880065

VL - 90

SP - 526

EP - 531

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 4

ER -